The Seremban Diabetes Cohort Study welcomes interested researchers, industries, and collaborators from around the world to participate in the study. Collaboration is encouraged as it helps maximize the scientific impact and enrich the available data of the 9,770 participants, including 3,650 diabetic individuals and their 4,600 family members, over a 12-year follow-up period.
The primary aim of the study is to identify the common causes and characteristics related to the development of diabetes and its complications. Access to the data will be granted on request, and data sharing will be monitored by the Steering Committee to ensure the best interests of the consented individuals, as well as to foster impactful research discoveries related to personalized patient management and care.
To facilitate access and ensure optimal scientific outcomes, the Seremban Diabetes Cohort Committee kindly requests all potential Principal Investigators (collaborators) to submit the following documents to sediahelpdesk@imu.edu.my:
Click here to explore opportunities for collaborations.
SeDia Cohort is established, maintained and governed as a collaborative public-private partnership between the Ministry of Health (MOH), Malaysia and the International Medical University (IMU), Kuala Lumpur. The MOH will be represented by Negeri Sembilan Health Department and Seremban District Health Office.
